AVITA Medical, Inc. (RCEL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$40.19M

Year ended 2025-12-31

-$32.71M

Trailing 12 months to 2026-06-30

2018-06-30 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$40.19M	n/m	2026-02-12, From 2025-01-01
2024-12-31	-$55.47M	n/m	2026-02-12, From 2024-01-01
2023-12-31	-$42.02M	n/m	2025-02-13, From 2023-01-01
2022-12-31	-$26.94M	n/a	2024-02-22, From 2022-01-01
No annual figure between 2021-06-30 and 2022-12-31.
2021-06-30	-$25.82M	n/m	2023-02-23, From 2020-07-01
2020-06-30	-$42.21M	n/m	2021-08-26, From 2019-07-01
2019-06-30	-$25.26M	n/m	2021-08-26, From 2018-07-01
2018-06-30	-$13.73M	n/a	2020-08-27, From 2017-07-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
AVITA Medical, Inc. (RCEL)	2025-12-31	-$40.19M	n/m
Sight Sciences, Inc. (SGHT)	2025-12-31	-$36.61M	n/m
PRO DEX Inc (PDEX)	2026-06-30	$14.38M	+20.6%
Iradimed Corp (IRMD)	2025-12-31	$27.31M	+19.9%
Kestra Medical Technologies, Ltd. (KMTS)	2026-04-30	-$126.03M	n/m
Apyx Medical Corp (APYX)	2025-12-31	-$5.79M	n/m
Carlsmed, Inc. (CARL)	2025-12-31	-$30.29M	n/m
Anika Therapeutics, Inc. (ANIK)	2025-12-31	-$5.68M	n/m
TriSalus Life Sciences, Inc. (TLSI)	2025-12-31	-$26.32M	n/m

Compare RCEL, SGHT, PDEX, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗